Cue Biopharma, Inc. (CUE)
NASDAQ: CUE · Real-Time Price · USD
28.85
+2.09 (7.81%)
At close: Aug 26, 2026, 4:00 PM EDT
28.33
-0.52 (-1.80%)
After-hours: Aug 26, 2026, 7:41 PM EDT
Cue Biopharma Market Cap
Cue Biopharma has a market cap or net worth of $209.58 million as of August 26, 2026. Its market cap has increased by 233.19% in one year.
Market Cap
209.58M
Enterprise Value
195.24M
1-Year Change
233.19%
Ranking
Category
Stock Price
$28.85
ChartMarket Cap Chart
Since January 2, 2018, Cue Biopharma's market cap has increased from $193.50M to $209.58M, an increase of 8.31%. That is a compound annual growth rate of 0.93%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 26, 2026 | 209.58M | 773.24% |
| Dec 31, 2025 | 24.00M | -65.27% |
| Dec 31, 2024 | 69.10M | -41.98% |
| Dec 29, 2023 | 119.10M | 18.15% |
| Dec 30, 2022 | 100.80M | -71.94% |
| Dec 31, 2021 | 359.20M | -5.17% |
| Dec 31, 2020 | 378.80M | 3.78% |
| Dec 31, 2019 | 365.00M | 285.84% |
| Dec 31, 2018 | 94.60M | -51.11% |
| Jan 2, 2018 | 193.50M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nkarta | 185.51M |
| Humacyte | 183.96M |
| Codexis | 181.78M |
| Caribou Biosciences | 175.82M |
| Canton Strategic Holdings | 170.52M |
| Spruce Biosciences | 168.56M |
| MediWound | 167.83M |
| Molecular Partners AG | 165.16M |